BASELINE TYPE 2 BIOMARKERS AS PREDICTORS OF MULTICOMPONENT CLINICAL REMISSION FOLLOWING DUPILUMAB TREATMENT IN PATIENTS WITH MODERATE-TO-SEVERE ASTHMA

GIORGIO WALTER Canonica; IAN D Pavord; SIMON Couillard; GUY G Brusselle; MARIO Castro; ARNAUD Bourdin; ARMAN Altincatal; JASON Kwah; OLIVIER Ledanois; LUIS PEREZ DE LLANO

doi:10.1016/j.chest.2025.07.022

Retour

BASELINE TYPE 2 BIOMARKERS AS PREDICTORS OF MULTICOMPONENT CLINICAL REMISSION FOLLOWING DUPILUMAB TREATMENT IN PATIENTS WITH MODERATE-TO-SEVERE ASTHMA

Article de revue

Avec comité de lecture

BASELINE TYPE 2 BIOMARKERS AS PREDICTORS OF MULTICOMPONENT CLINICAL REMISSION FOLLOWING DUPILUMAB TREATMENT IN PATIENTS WITH MODERATE-TO-SEVERE ASTHMA

GIORGIO WALTER Canonica, IAN D Pavord, SIMON Couillard, GUY G Brusselle, MARIO Castro, ARNAUD Bourdin, ARMAN Altincatal, JASON Kwah, OLIVIER Ledanois et LUIS PEREZ DE LLANO

Chest, Vol.168(4), pp.A40-A43

10/2025

DOI: https://doi.org/10.1016/j.chest.2025.07.022

Indicateurs

1 Consultations de la notice

Détails

Titre: BASELINE TYPE 2 BIOMARKERS AS PREDICTORS OF MULTICOMPONENT CLINICAL REMISSION FOLLOWING DUPILUMAB TREATMENT IN PATIENTS WITH MODERATE-TO-SEVERE ASTHMA
Créateurs - sans rôle: GIORGIO WALTER Canonica
IAN D Pavord
SIMON Couillard
GUY G Brusselle
MARIO Castro
ARNAUD Bourdin
ARMAN Altincatal
JASON Kwah
OLIVIER Ledanois
LUIS PEREZ DE LLANO
Détails de publication: Chest, Vol.168(4), pp.A40-A43
Identifiants: 99158853809311
Unité académique: Physiologie et Médecine Expérimentale du coeur et des muscles - PhyMedExp
Langue: English
Type de ressource: Journal article